DEMO CONTACT US
Logo MetaQare
+ + + + +
Investor corner · Métricas · Roadmap

Building the world's clinical intelligence infrastructure.

Materiales para inversores: tesis, one-pager, KPIs, roadmap y contacto. Diseñado para acelerar due diligence y habilitar conversaciones eficientes (deck bajo NDA).

Scroll
SaMD IIaAEMPS certified — zero EU competitors
ProfitableQsalud SL net profit FY2025
KPIs220,000 insured lives
RoadmapSeries A
Specialty Centers

Investor materials

One-pager, deck and data room (under NDA).

/investors · /contact (Investors)

KPIs

Métricas operativas, clínicas y de crecimiento.

Uptime · SLA · Outcomes · ROI

Roadmap

Activation → Scaling → Platform.

Phase 1 · Phase 2 · Phase 3

One-pager

Thesis

La salud global necesita una capa de inteligencia clinical intelligence layer: secure, auditable and deployable. MetaQare builds it.

Product

Ecosistema por capas: Qarefy (operación) + 1coma3 (inteligencia clínica) + MetaQare.ai (plataforma).

Market

Aseguradoras, hospitales y empresas requieren eficiencia, control y confianza regulatoria para IA clínica.

KPIs we report

Growth

  • Active partners
  • Geographic coverage
  • Deployed specialties
  • Active users (by vertical)

Operations

  • SLA/latencia
  • Resolution rate
  • Cost per case
  • NPS/CSAT

Clinical

  • Protocol adherence
  • Reported adverse events
  • Appropriate referrals
  • Outcomes by cohort (when applicable)

Technology

  • Uptime
  • Incidents and MTTR
  • Audit compliance
  • Deployment times by country

Investor Deck

Sent under NDA

Resumen ejecutivo, visión, arquitectura, roadmap, unit economics y estrategia de expansión. Solicítalo por el formulario de contacto.

Data Room

Acceso a documentos clave: compliance, IP, contratos, métricas, finanzas y roadmap.

Contact

Canal directo con el equipo fundador y liderazgo (en /contact).

High-level Roadmap

Phase 1 — Controlled activation

Pilotos acotados por entidad y caso de uso; validación y KPIs.

Phase 2 — Scaling

Despliegue multi-país, estandarización, automatización operativa y expansión de especialidades.

Phase 3 — Platform

Analítica poblacional avanzada, marketplace de capabilities clínicas y data governance ampliada.

Live Metrics · Updated Q1 2026

220,000Insured lives in active pilot
500+Named physician authors across 18 specialties
12Countries with active clinical protocols
99.9%Platform uptime SLA
SaMD IIaAEMPS certification · verbal March 2026 · written Q2 2026
Full KPI dashboard and unit economics available in data room (NDA required).

Investor Interest

To receive the one-pager and deck, request access at /contact and select "Investors". Typical response: 24–48h business days.
This page is intended for accredited investors only. Nothing herein constitutes an offer to sell or solicitation of an offer to buy securities. Financial details are available under NDA in the data room. Past performance (FY2025 audited results of Qsalud SL) is not indicative of future results. AEMPS SaMD Class IIa classification reflects verbal confirmation (March 2026); written certification expected Q2 2026.